The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Travelers Vaccines Market Research Report 2024
Synopsis
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
The global Travelers Vaccines market was valued at US$ 3363.3 million in 2023 and is anticipated to reach US$ 6111.4 million by 2030, witnessing a CAGR of 8.8% during the forecast period 2024-2030.
Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.
This report aims to provide a comprehensive presentation of the global market for Travelers Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Travelers Vaccines.
Report Scope
The Travelers Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Travelers Vaccines market comprehensively. Regional market sizes, concerning products by Type, by End Users, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Travelers Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by End Users, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
Segment by Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Segment by End Users
Tourists
Students
Workers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by End Users, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Travelers Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Travelers Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End Users, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
The global Travelers Vaccines market was valued at US$ 3363.3 million in 2023 and is anticipated to reach US$ 6111.4 million by 2030, witnessing a CAGR of 8.8% during the forecast period 2024-2030.
Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.
This report aims to provide a comprehensive presentation of the global market for Travelers Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Travelers Vaccines.
Report Scope
The Travelers Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Travelers Vaccines market comprehensively. Regional market sizes, concerning products by Type, by End Users, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Travelers Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by End Users, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
Segment by Type
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Segment by End Users
Tourists
Students
Workers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by End Users, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Travelers Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Travelers Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End Users, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Travelers Vaccines Market Overview
1.1 Product Overview and Scope of Travelers Vaccines
1.2 Travelers Vaccines Segment by Type
1.2.1 Global Travelers Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Meningococcal Vaccine
1.2.3 Japanese Encephalitis Vaccine
1.2.4 Yellow Fever Vaccine
1.2.5 Hepatitis Vaccine
1.2.6 Cholera Vaccine
1.2.7 Other
1.3 Travelers Vaccines Segment by End Users
1.3.1 Global Travelers Vaccines Market Value by End Users: (2024-2030)
1.3.2 Tourists
1.3.3 Students
1.3.4 Workers
1.3.5 Others
1.4 Global Travelers Vaccines Market Size Estimates and Forecasts
1.4.1 Global Travelers Vaccines Revenue 2019-2030
1.4.2 Global Travelers Vaccines Sales 2019-2030
1.4.3 Global Travelers Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Travelers Vaccines Market Competition by Manufacturers
2.1 Global Travelers Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Travelers Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Travelers Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Travelers Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Travelers Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Travelers Vaccines, Product Type & Application
2.7 Travelers Vaccines Market Competitive Situation and Trends
2.7.1 Travelers Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Travelers Vaccines Players Market Share by Revenue
2.7.3 Global Travelers Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Travelers Vaccines Retrospective Market Scenario by Region
3.1 Global Travelers Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Travelers Vaccines Global Travelers Vaccines Sales by Region: 2019-2030
3.2.1 Global Travelers Vaccines Sales by Region: 2019-2024
3.2.2 Global Travelers Vaccines Sales by Region: 2025-2030
3.3 Global Travelers Vaccines Global Travelers Vaccines Revenue by Region: 2019-2030
3.3.1 Global Travelers Vaccines Revenue by Region: 2019-2024
3.3.2 Global Travelers Vaccines Revenue by Region: 2025-2030
3.4 North America Travelers Vaccines Market Facts & Figures by Country
3.4.1 North America Travelers Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Travelers Vaccines Sales by Country (2019-2030)
3.4.3 North America Travelers Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Travelers Vaccines Market Facts & Figures by Country
3.5.1 Europe Travelers Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Travelers Vaccines Sales by Country (2019-2030)
3.5.3 Europe Travelers Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Travelers Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Travelers Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Travelers Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Travelers Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Travelers Vaccines Market Facts & Figures by Country
3.7.1 Latin America Travelers Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Travelers Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Travelers Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Travelers Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Travelers Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Travelers Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Travelers Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Travelers Vaccines Sales by Type (2019-2030)
4.1.1 Global Travelers Vaccines Sales by Type (2019-2024)
4.1.2 Global Travelers Vaccines Sales by Type (2025-2030)
4.1.3 Global Travelers Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Travelers Vaccines Revenue by Type (2019-2030)
4.2.1 Global Travelers Vaccines Revenue by Type (2019-2024)
4.2.2 Global Travelers Vaccines Revenue by Type (2025-2030)
4.2.3 Global Travelers Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Travelers Vaccines Price by Type (2019-2030)
5 Segment by End Users
5.1 Global Travelers Vaccines Sales by End Users (2019-2030)
5.1.1 Global Travelers Vaccines Sales by End Users (2019-2024)
5.1.2 Global Travelers Vaccines Sales by End Users (2025-2030)
5.1.3 Global Travelers Vaccines Sales Market Share by End Users (2019-2030)
5.2 Global Travelers Vaccines Revenue by End Users (2019-2030)
5.2.1 Global Travelers Vaccines Revenue by End Users (2019-2024)
5.2.2 Global Travelers Vaccines Revenue by End Users (2025-2030)
5.2.3 Global Travelers Vaccines Revenue Market Share by End Users (2019-2030)
5.3 Global Travelers Vaccines Price by End Users (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Travelers Vaccines Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Pasteur Travelers Vaccines Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Travelers Vaccines Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Travelers Vaccines Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 CNBG
6.5.1 CNBG Corporation Information
6.5.2 CNBG Description and Business Overview
6.5.3 CNBG Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CNBG Travelers Vaccines Product Portfolio
6.5.5 CNBG Recent Developments/Updates
6.6 Sanofi Pasteur MSD
6.6.1 Sanofi Pasteur MSD Corporation Information
6.6.2 Sanofi Pasteur MSD Description and Business Overview
6.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sanofi Pasteur MSD Travelers Vaccines Product Portfolio
6.6.5 Sanofi Pasteur MSD Recent Developments/Updates
6.7 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Serum Institute of India Travelers Vaccines Product Portfolio
6.7.5 Serum Institute of India Recent Developments/Updates
6.8 Biokangtai
6.8.1 Biokangtai Corporation Information
6.8.2 Biokangtai Description and Business Overview
6.8.3 Biokangtai Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biokangtai Travelers Vaccines Product Portfolio
6.8.5 Biokangtai Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Travelers Vaccines Industry Chain Analysis
7.2 Travelers Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Travelers Vaccines Production Mode & Process
7.4 Travelers Vaccines Sales and Marketing
7.4.1 Travelers Vaccines Sales Channels
7.4.2 Travelers Vaccines Distributors
7.5 Travelers Vaccines Customers
8 Travelers Vaccines Market Dynamics
8.1 Travelers Vaccines Industry Trends
8.2 Travelers Vaccines Market Drivers
8.3 Travelers Vaccines Market Challenges
8.4 Travelers Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
